Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MEG.0000000000001945 | DOI Listing |
Publication Analysis
Top Keywords
adalimumab-induced leukocytoclastic
4
leukocytoclastic vasculitis
4
vasculitis crohn's
4
crohn's disease
4
disease patient
4
adalimumab-induced
1
vasculitis
1
crohn's
1
disease
1
patient
1
Similar Publications
Article Synopsis
- Patients on anti-TNF-α drugs for ankylosing spondylitis (AS) should be closely monitored for symptoms like purpuric and ischemic skin lesions to catch potential drug-induced issues early.
- A case study highlighted a 38-year-old woman who developed skin lesions after starting adalimumab, leading to a diagnosis of vasculitis linked to the medication.
- Stopping adalimumab and switching to other treatments like glucocorticoids and cyclophosphamide successfully resolved her skin issues, emphasizing the need to be aware of medication side effects in AS patients.
Adalimumab-induced leukocytoclastic vasculitis in a Crohn's disease patient.
Eur J Gastroenterol Hepatol
March 2021
Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!